The study included more than 73,000 adult COVID-19 patients who were hospitalized in the U.K. between Jan. 17 and Aug. 4, 2020. The average age of patients in the study cohort was 71.1. Fifty-six percent were men and 81 percent had at least one comorbidity.
Overall, 48.1 percent had at least one complication.
Four more findings:
1. The most common complications were renal (24.3 percent), complex respiratory (18.4 percent), and systemic complications (16.3 percent).
2. About 12 percent of patients developed a cardiovascular complication, 10.8 percent had a gastrointestinal or liver problem and 4.3 percent experienced a neurological complication.
3. Such complications were most common among men and those aged 60 and older.
4. However, researchers found a significant risk across age groups. Among patients in the 19-29 age group, about 27 percent developed a complication. For those aged 30-39, about 37 percent developed another complication.
“Complications and worse functional outcomes in patients admitted to hospital with COVID-19 are high, even in young, previously healthy individuals,” researchers said. “COVID-19 complications are likely to cause a substantial strain on health and social care in the coming years.”
To view the full findings, click here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
